Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Anaphylaxis: assessment and referral after emergency treatment

Clinical guideline
Reference number: CG134
Published: 14 December 2011
Last updated: 24 August 2020

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 264 KB)

Published:

19 August 2016
Comments form (MSWord 27 KB)

Published:

23 August 2016

Stakeholder list updated

Stakeholder list (PDF 44 KB)

Published:

18 August 2016

Review documents

CG134 Anaphylaxis: surveillance review decision August 2014 (PDF 175 KB)

Published:

08 September 2014

Other information

CG134 Anaphylaxis: evidence update (PDF 359 KB)

Published:

01 March 2014

Anaphylaxis: pre-publication check

Anaphylaxis: pre-publication check information
Anaphylaxis: pre-publication check error reporting table (PDF 178 KB)

Published:

14 December 2011
Anaphylaxis: full guideline (PDF 871 KB)

Published:

10 October 2011
Anaphylaxis: appendices
Anaphylaxis: appendix C and D - scope and how this guidance was developed (PDF 300 KB)

Published:

10 October 2011
Anaphylaxis: appendix E - evidence tables (PDF 861 KB)

Published:

10 October 2011
Anaphylaxis: appendix F - full health economic report (PDF 886 KB)

Published:

10 October 2011
Anaphylaxis: appendix G - technology assessment report (PDF 845 KB)

Published:

10 October 2011
Anaphylaxis: consultation table with developer's responses (PDF 784 KB)

Published:

10 October 2011
Appendices to full guideline

Anaphylaxis: guideline development and consultation

Anaphylaxis: guideline development and consultation
Anaphylaxis: equality impact assessment form (PDF 106 KB)

Published:

14 December 2011
Anaphylaxis: guideline consultation information
Anaphylaxis: full guideline (PDF 728 KB)

Published:

11 July 2011
Anaphylaxis: appendices
Anaphylaxis: appendix C - scope (PDF 340 KB)

Published:

11 July 2011
Anaphylaxis: appendix E - evidence tables (PDF 1.11 MB)

Published:

11 July 2011
Anaphylaxis: appendix F - full health economic report (PDF 660 KB)

Published:

11 July 2011
Anaphylaxis: appendix G - technology assessment report (PDF 985 KB)

Published:

11 July 2011
Anaphylaxis: economic model - confidentiality agreement (PDF 36 KB)

Published:

11 July 2011
Appendices
Anaphylaxis: stakeholder list (PDF 13 KB)

Published:

14 October 2011
Anaphylaxis: GDG minutes
Anaphylaxis: GDG 1 minutes - 9 - 10th December 2010 (PDF 48 KB)

Published:

04 August 2011
Anaphylaxis: GDG 2 minutes - 3rd February 2011 (PDF 30 KB)

Published:

04 August 2011
Anaphylaxis: GDG 3 minutes - 6 - 7th April 2011 (PDF 30 KB)

Published:

04 August 2011
Anaphylaxis: GDG 4 minutes - 6 - 7th June 2011 (PDF 30 KB)

Published:

04 August 2011
Anaphylaxis: GDG membership list (PDF 45 KB)

Published:

14 July 2011

Anaphylaxis: scoping workshop, consultation and final scope

Anaphylaxis: scoping workshop, consultation and final scope
Anaphylaxis: equality impact assessment form (scoping) (PDF 10 KB)

Published:

17 February 2011
Anaphylaxis: final scope (PDF 61 KB)

Published:

14 December 2010
Anaphylaxis: stakeholder comments and developer responses to scope (PDF 260 KB)

Published:

14 December 2010
Anaphylaxis: draft scope consultation information
Anaphylaxis: draft scope (PDF 67 KB)

Published:

01 September 2010
Anaphylaxis: comments proforma (MSWord 44 KB)

Published:

01 September 2010
Anaphylaxis: stakeholder list (PDF 13 KB)

Published:

14 October 2011
Anaphylaxis: scoping workshop notes (PDF 60 KB)

Published:

04 November 2010

Anaphylaxis: remit

Anaphylaxis: remit (PDF 17 KB)

Published:

18 November 2009